Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2000

01-12-2001 | Paper Report

FAK, fibronectin and paxillin in chondrogenic cell condensation

Author: Lillian Shum

Published in: Arthritis Research & Therapy | Issue 1/2000

Login to get access

Excerpt

Chondrogenesis is a multi-step process that encompasses an initiation phase during which chondroprogenitor cells are recruited, followed by processes of proliferation, cell condensation and nodule formation, and culminates in overt differentiation. Cell condensation, the aggregation of a dispersed population of cells, is an essential stage during which cell - cell and cell - matrix interactions produce orchestrated signaling within and among precartilage cells directed towards differentiation. In many other differentiation systems, matrix signaling, with focal adhesion complex assembly and cytoskeletal rearrangement are pivotal events. The authors hypothesized that, during chondrogenesis, activation and assembly of focal adhesion complex are necessary steps for precartilage cell condensation. …
Literature
1.
go back to reference Bang O-S, Kim E-J, Chung J-G, Lee S-R, Park T-K, Kang S-S: Association of focal adhesion kinase with fibronectin and paxillin is required for precartilage condensation of chick mesenchymal cells. Biochem Biophys Res Commun. 2001, 278: 522-529.CrossRef Bang O-S, Kim E-J, Chung J-G, Lee S-R, Park T-K, Kang S-S: Association of focal adhesion kinase with fibronectin and paxillin is required for precartilage condensation of chick mesenchymal cells. Biochem Biophys Res Commun. 2001, 278: 522-529.CrossRef
Metadata
Title
FAK, fibronectin and paxillin in chondrogenic cell condensation
Author
Lillian Shum
Publication date
01-12-2001
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2000
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar-2001-66877

Other articles of this Issue 1/2000

Arthritis Research & Therapy 1/2000 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine